Found 24 matching trials
Phase II Trial of HM781-36B in Patients With Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of or Unfit for Platinum-containing Therapy PHASE2 Head and neck cancer is the sixth most common cancer and more than 650,000 ...
Show More Location
Yonsei University
Learn More & Join Trial
NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma PHASE2 The purpose of this open-label, single-arm, multi-center phase II trial is ...
Show More Location
National Cancer Center
Learn More & Join Trial
A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations PHASE3 The primary purpose of this study is to compare the progression-free surviv...
Show More Location
Bond Clinic, P.A.
Learn More & Join Trial
Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors PHASE1 The main objective of this study is to determine the maximum tolerated dose...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to Poziotinib PHASE2 This is an open-label extension study (Extension Study) designed to allow p...
Show More Location
Pacific Shores Medical Group
Learn More & Join Trial
A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway PHASE2 Metastatic breast cancer (MBC) is an incurable disease and is needed to imp...
Show More Location
Samsung Medical Center
Learn More & Join Trial
A Mass Balance and Pharmacokinetics Study of 14C-Labeled Poziotinib in Cancer Patients Suitable for Treatment With Poziotinib PHASE1 The purpose of this study is to determine routes of excretion and single-do...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial
Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens PHASE2 The purpose of this study is to evaluate the efficacy and safety of novel p...
Show More Location
National Cancer Center
Learn More & Join Trial
A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC) PHASE2 Esophageal cancer is the sixth most common cause of cancer deaths worldwide...
Show More Location
Severance Hospital
Learn More & Join Trial
NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors PHASE2 The purpose of this open-label, single-arm, multi-center phase II trial is ...
Show More Location
National Cancer Center
Learn More & Join Trial